ENDPOINTS NEWS3m
Can­del's vi­ral ther­a­py shows promis­ing sur­vival in small pan­cre­at­ic can­cer study
To Can­del Ther­a­peu­tics CEO Paul Pe­ter Tak, the biotech’s vi­ral im­munother­a­py has passed the “bloody ob­vi­ous test” ...
Genetic testing for cancer should be the norm now, experts say. Here’s when to request it.
Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...